IFRX Earnings & Financial Statements
InflaRx N.V.
$1.48
-$0.07(-4.52%)
37
Overall
60
Value
18
Tech
34
Quality
Market Cap
$218.10M
Volume
585.63K
52W Range
$0.80 - $2.95
Target Price
$8.25
IFRX earnings and financial statements: InflaRx N.V.'s income statement, balance sheet and cash flow statement, annual and quarterly.
IFRX Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $29.3K | $165.8K | $63.1K | - | - |
| Cost of revenue | $7.27M | $3.32M | $532.3K | - | $47.68M |
| Operating income | -$50.94M | -$58.30M | -$58.13M | -$52.44M | -$47.71M |
| EBITDA | -$45.18M | -$52.90M | -$38.95M | -$54.19M | -$83.83M |
| Net income | -$45.63M | -$53.40M | -$38.98M | -$54.76M | -$84.48M |
| EPS (diluted) | $-0.68 | $-0.78 | $-0.78 | $-0.67 | $-1.10 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $55.22M | $76.02M | $120.21M | $102.40M | $125.14M |
| Total liabilities | $13.66M | $14.60M | $17.63M | $14.05M | $55.75M |
| Shareholders’ equity | $41.56M | $61.42M | $102.58M | $7.26M | $66.34M |
| Cash and equivalents | $16.02M | $18.38M | $12.77M | $16.27M | $26.25M |
| Long-term debt | $641.0K | $399.1K | $745.7K | $987.3K | $1.07M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$35.31M | -$48.56M | -$37.81M | -$33.74M | -$37.93M |
| Capital expenditure | - | - | - | -$162.4K | -$37.8K |
| Free cash flow | -$35.43M | -$48.60M | -$37.89M | -$33.91M | -$37.97M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | IFRX | $1.48 | -4.5% | 585.63K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |